- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Industry turnover for leading pharmaceuticals German 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Industry turnover for leading pharmaceuticals German 2017
Industry turnover for leading pharmaceuticals in Germany in 2017 (in million euros)
by Evgeniya Koptyug,
last edited
May 13, 2019
This statistic shows the industry turnover of leading pharmaceuticals in Germany in 2017. That year, the pharmaceutical company Bayer achieved a turnover of 410.6 million euros with its drug Xarelto. The highest turnover was achieved by Abbott with Humira, at 782.4 million euros.
Industry turnover for leading pharmaceuticals in Germany in 2017 (in million euros)
| Product (manufacturer) | Turnover in million euros |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Product (manufacturer) | Turnover in million euros |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Evgeniya Koptyug,
last edited
May 13, 2019
This statistic shows the industry turnover of leading pharmaceuticals in Germany in 2017. That year, the pharmaceutical company Bayer achieved a turnover of 410.6 million euros with its drug Xarelto. The highest turnover was achieved by Abbott with Humira, at 782.4 million euros.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- April 2019
- Region
- Germany
- Survey time period
- 2017
- Supplementary notes
-
Total market industry turnover in 2017: 32.34 billion euros.
Total packaging market in 2017: 1.48 billion packages.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- April 2019
More information
- Region
- Germany
- Survey time period
- 2017
- Supplementary notes
-
Total market industry turnover in 2017: 32.34 billion euros.
Total packaging market in 2017: 1.48 billion packages.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Sales revenue of medicaments via physical retail pharmacies in China 2011-2018
- Boehringer Ingelheim's top self-medication drugs revenues 2008-2016
- Export value of medicinal and pharmaceutical products from China 2017
- Rx medicine out-of-pocket expense per person by insurance status 1987-2014
- Rx medicine out-of-pocket expense per person by gender in the U.S. 1987-2014
- Rx medicine out-of-pocket expense per person by age in the U.S. 1987-2014
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Mexico: public medicine expenditure 2012-2018, by supplier
- Top specialty drug pharmacies in the U.S. by revenue 2018
- Top specialty drug pharmacies in the U.S. based on market share 2018
- Median duration of drug shortages in Canada 2013-2016
- Zolpidem and drug combinations leading to ED visits in the U.S. 2010
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Share of drug dispensing costs in select public drug plans Canada 2011-2017
- Medicine spending share globally in 2007,2017 and 2023, by country group
Studies
- Personalized medicine
- Prescribed Drug Spending in Canada, 2018
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- CDER 2018 New Drug Therapy Approvals
- Patented Medicine Prices Review Board - Annual Report 2017
- Drug Use Among Seniors in Canada, 2016
- Prescribed Drug Spending in Canada, 2017
- CDER 2017 New Drug Therapy Approvals
- Antibiotic use in the United Kingdom (UK)
- Patented Medicine Prices Review Board - Annual Report 2016
- Meds Entry Watch 2017
- CDER New Drugs Program: 2018 Update
- Prescription Cost Analysis, England 2018
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Showdown over drug pricing
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Expenditure on specialty medicines in the United States from 2012 to 2016, by type (in billion U.S. dollars)
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Sales revenue of medicine through physical retail pharmacies as end sales channel in China from 2011 to 2018 (in billion yuan)
- Revenues of Boehringer Ingelheim's top self-medication products 2008 to 2016 (in million euros)
- Export value of medicinal and pharmaceutical products from China between 2009 and 2017 (in million U.S. dollars)
- Mean annual out-of-pocket expense per person for prescribed medicine in the U.S. from 1987 to 2014, by insurance status*
- Mean annual out-of-pocket expense per person for prescribed medicine in the U.S. from 1987 to 2014, by gender*
- Mean annual out-of-pocket expense per person for prescribed medicine in the U.S. from 1987 to 2014, by age group*
- Mean annual out-of-pocket expense per person for prescribed medicine in the U.S. from 1987 to 2014*
- Value of governmental medicine spending in Mexico between 2012 and 2018, by supplier (in billion Mexican pesos)
- Top 10 pharmacies based on specialty drug revenue in the U.S. in 2018 (in billion U.S. dollars)
- Top specialty drug pharmacies in the United States based on market share in 2018
- Median number of days of drug shortages in Canada from 2013 to 2016
- Selected drug combinations in U.S. zolpidem-related Emergency department visits in 2010*
- Distribution of drug dispensing costs by drug type in select public Canadian drug plans as of FY 2015/16*
- Dispensing costs as share of total Rx drug costs in select public drug plans in Canada from 2011/2012 to 2016/2017
- Global medicine spending distribution in 2007, 2018 and 2023, by country group
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.